Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by N Zengin
Efficacy of Adjuvant Aromatase Inhibitor in Hormone Receptor-Positive Postmenopausal Breast Cancer Patients According to the Body Mass Index
British Journal of Cancer
Cancer Research
Oncology
Related publications
The Aromatase Inhibitors as Adjuvant Therapy for Hormone Receptor-Positive Breast Cancer
Journal of the National Comprehensive Cancer Network : JNCCN
Medicine
Oncology
Low P27 Expression Predicts Early Relapse and Death in Postmenopausal Hormone Receptor-Positive Breast Cancer Patients Receiving Adjuvant Tamoxifen Therapy
Clinical Cancer Research
Cancer Research
Oncology
Adjuvant Endocrine Monotherapy for Postmenopausal Early Breast Cancer Patients With Hormone-Receptor Positive: A Systemic Review and Network Meta-Analysis
Breast Cancer
Nuclear Medicine
Radiology
Pharmacology
Oncology
Imaging
Medicine
Accumulation of P53 Is Prognostic for Aromatase Inhibitor Resistance in Early-Stage Postmenopausal Patients With ER-positive Breast Cancer
OncoTargets and Therapy
Oncology
Pharmacology
Anastrozole as Aromatase Inhibitor – New Approaches to Breast Cancer Treatment in Postmenopausal Women
Nowotwory
Cancer Research
Oncology
Thyroid Hormones and Breast Cancer Association According to Menopausal Status and Body Mass Index
Breast Cancer Research
Cancer Research
Oncology
(557) Auricular Point Acupressure to Manage Aromatase Inhibitor-Induced Arthralgia in Postmenopausal Breast Cancer Survivors
Journal of Pain
Neurology
Anesthesiology
Pain Medicine
Deficiencies in Immunoassay Methods Used to Monitor Serum Estradiol Levels During Aromatase Inhibitor Treatment in Postmenopausal Breast Cancer Patients
SpringerPlus
Multidisciplinary
Osteoporosis Therapy and Outcomes for Postmenopausal Patients With Hormone Receptor-Positive Breast Cancer: NCIC CTG MA.27
Cancer
Cancer Research
Oncology
